Mutational analysis of APOL1 in patients with Fechtner and Epstein syndromes: no evidence of a digenic etiology in MYH9-related disorders with renal disease

Mutations in MYH9 result in a group of clinically overlapping autosomal dominant macrothrombocytopenia syndromes, collectively termed the MYH9-related disorders (MYH9RD). Intriguingly, three of these disorders, Fechtner, Alport-like, and Epstein syndromes, are associated with the additional clinical...

Full description

Saved in:
Bibliographic Details
Published in:Advances in genomics and genetics 2012-07, Vol.2, p.49
Main Authors: McGredy, Maxine, Martignetti, John A, Babcock, Melanie
Format: Article
Language:English
Subjects:
Kidney diseases
Mutation
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mutations in MYH9 result in a group of clinically overlapping autosomal dominant macrothrombocytopenia syndromes, collectively termed the MYH9-related disorders (MYH9RD). Intriguingly, three of these disorders, Fechtner, Alport-like, and Epstein syndromes, are associated with the additional clinical phenotype of glomerulosclerosis. Recently, an abundance of studies have demonstrated that the APOL1 gene, contiguous to MYH9, is associated with a form of kidney disease in individuals of African ancestry. Given these findings related to kidney disease arising in mutations in two contiguous genes, this study aimed to determine whether APOL1 mutations could also be present in patients with Fechtner (FTNS) and Epstein (EPS) syndromes. This study used sequence analysis to investigate a discrete discovery set of FTNS patients, but did not identify second hit mutations in APOL1.
ISSN:1179-9870
1179-9870
DOI:10.2147/AGG.S32886